 Maggie Stanislawski
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 8 | 2023 | 502 | 2.460 |
Why?
| | Microbiota | 8 | 2023 | 651 | 1.880 |
Why?
| | Obesity | 7 | 2023 | 2529 | 1.040 |
Why?
| | United States Department of Veterans Affairs | 14 | 2020 | 556 | 0.860 |
Why?
| | Body Mass Index | 6 | 2020 | 1982 | 0.860 |
Why?
| | Percutaneous Coronary Intervention | 11 | 2020 | 440 | 0.840 |
Why?
| | Behavior Therapy | 2 | 2021 | 227 | 0.830 |
Why?
| | Fatty Liver | 2 | 2021 | 217 | 0.760 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2021 | 85 | 0.740 |
Why?
| | Weight Loss | 2 | 2021 | 631 | 0.710 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 288 | 0.680 |
Why?
| | Biostatistics | 1 | 2018 | 17 | 0.630 |
Why?
| | Coronary Artery Disease | 6 | 2023 | 611 | 0.600 |
Why?
| | Weight Gain | 2 | 2018 | 454 | 0.600 |
Why?
| | Pacemaker, Artificial | 4 | 2020 | 104 | 0.590 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 169 | 0.560 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2021 | 2021 | 0.550 |
Why?
| | Bacteria | 3 | 2020 | 731 | 0.540 |
Why?
| | Insulin Resistance | 2 | 2021 | 1077 | 0.530 |
Why?
| | Phylogeny | 2 | 2018 | 802 | 0.520 |
Why?
| | Pediatric Obesity | 2 | 2019 | 492 | 0.500 |
Why?
| | Prosthesis-Related Infections | 4 | 2020 | 70 | 0.490 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 245 | 0.490 |
Why?
| | Antibiotic Prophylaxis | 3 | 2020 | 96 | 0.470 |
Why?
| | Feces | 4 | 2021 | 374 | 0.460 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2018 | 492 | 0.460 |
Why?
| | Liver | 2 | 2020 | 1693 | 0.460 |
Why?
| | Phenotype | 4 | 2023 | 2858 | 0.450 |
Why?
| | Veterans Health | 4 | 2018 | 165 | 0.440 |
Why?
| | Risk Factors | 15 | 2023 | 8714 | 0.410 |
Why?
| | Coronary Artery Bypass | 4 | 2017 | 195 | 0.390 |
Why?
| | Pregnancy | 4 | 2021 | 5553 | 0.380 |
Why?
| | Female | 35 | 2023 | 60049 | 0.370 |
Why?
| | Humans | 43 | 2023 | 115847 | 0.350 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 1724 | 0.340 |
Why?
| | Veterans | 7 | 2018 | 1232 | 0.340 |
Why?
| | Male | 31 | 2023 | 56104 | 0.340 |
Why?
| | Middle Aged | 26 | 2023 | 27064 | 0.320 |
Why?
| | Myocardial Infarction | 6 | 2018 | 931 | 0.310 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2090 | 0.300 |
Why?
| | Bifidobacterium | 2 | 2017 | 21 | 0.300 |
Why?
| | Coronary Angiography | 7 | 2020 | 313 | 0.280 |
Why?
| | Anti-Infective Agents | 2 | 2020 | 225 | 0.260 |
Why?
| | Aged | 21 | 2021 | 19283 | 0.260 |
Why?
| | Defibrillators, Implantable | 2 | 2020 | 279 | 0.250 |
Why?
| | Radial Artery | 2 | 2017 | 64 | 0.250 |
Why?
| | Time Factors | 10 | 2021 | 6186 | 0.250 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2018 | 445 | 0.250 |
Why?
| | Diet | 3 | 2023 | 1075 | 0.250 |
Why?
| | Child | 6 | 2021 | 18546 | 0.240 |
Why?
| | United States | 20 | 2020 | 12337 | 0.230 |
Why?
| | Registries | 3 | 2019 | 1773 | 0.230 |
Why?
| | Risk Assessment | 4 | 2021 | 3004 | 0.230 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2020 | 488 | 0.220 |
Why?
| | Electronic Health Records | 2 | 2020 | 801 | 0.220 |
Why?
| | Age Factors | 2 | 2021 | 2915 | 0.210 |
Why?
| | Metagenomics | 1 | 2023 | 132 | 0.210 |
Why?
| | Acute Kidney Injury | 2 | 2020 | 647 | 0.210 |
Why?
| | Mothers | 2 | 2018 | 667 | 0.200 |
Why?
| | Norway | 2 | 2018 | 36 | 0.200 |
Why?
| | Patient Identification Systems | 2 | 2019 | 17 | 0.200 |
Why?
| | Incidence | 4 | 2021 | 2333 | 0.200 |
Why?
| | Mississippi | 1 | 2021 | 20 | 0.190 |
Why?
| | Diet, Reducing | 1 | 2021 | 79 | 0.190 |
Why?
| | Waist Circumference | 1 | 2021 | 123 | 0.190 |
Why?
| | Caloric Restriction | 1 | 2021 | 87 | 0.180 |
Why?
| | Gardening | 1 | 2020 | 9 | 0.180 |
Why?
| | Adult | 9 | 2023 | 30787 | 0.180 |
Why?
| | Cohort Studies | 6 | 2020 | 4960 | 0.180 |
Why?
| | DNA, Bacterial | 2 | 2018 | 308 | 0.180 |
Why?
| | Fasting | 1 | 2021 | 241 | 0.180 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 91 | 0.180 |
Why?
| | Adolescent | 5 | 2021 | 17945 | 0.180 |
Why?
| | Atherosclerosis | 1 | 2023 | 339 | 0.170 |
Why?
| | Precision Medicine | 1 | 2023 | 356 | 0.170 |
Why?
| | Western World | 1 | 2019 | 6 | 0.170 |
Why?
| | Fluid Therapy | 1 | 2020 | 120 | 0.170 |
Why?
| | Proportional Hazards Models | 6 | 2018 | 1088 | 0.170 |
Why?
| | Cardiac Catheterization | 3 | 2018 | 535 | 0.170 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2019 | 15 | 0.170 |
Why?
| | Prospective Studies | 3 | 2021 | 6263 | 0.160 |
Why?
| | Perioperative Care | 1 | 2020 | 127 | 0.160 |
Why?
| | Young Adult | 5 | 2021 | 10503 | 0.160 |
Why?
| | Epidemiology | 1 | 2018 | 14 | 0.160 |
Why?
| | Practice Patterns, Physicians' | 2 | 2017 | 1177 | 0.160 |
Why?
| | Genome-Wide Association Study | 2 | 2023 | 1301 | 0.160 |
Why?
| | Documentation | 1 | 2020 | 169 | 0.150 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2017 | 751 | 0.150 |
Why?
| | Clostridium Infections | 1 | 2018 | 56 | 0.150 |
Why?
| | Drug Users | 1 | 2018 | 41 | 0.150 |
Why?
| | Streptococcus | 1 | 2017 | 23 | 0.150 |
Why?
| | Homeostasis | 1 | 2021 | 576 | 0.150 |
Why?
| | Genes, rRNA | 1 | 2017 | 39 | 0.150 |
Why?
| | History, 21st Century | 1 | 2018 | 164 | 0.150 |
Why?
| | Vancomycin | 1 | 2018 | 76 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2018 | 78 | 0.150 |
Why?
| | Atherectomy, Coronary | 1 | 2017 | 11 | 0.150 |
Why?
| | Coronary Stenosis | 1 | 2017 | 39 | 0.150 |
Why?
| | Contrast Media | 1 | 2020 | 365 | 0.150 |
Why?
| | Infant, Newborn | 2 | 2018 | 5088 | 0.150 |
Why?
| | Coronary Occlusion | 1 | 2017 | 18 | 0.140 |
Why?
| | Dysbiosis | 1 | 2018 | 145 | 0.140 |
Why?
| | Blood Transfusion | 2 | 2017 | 277 | 0.140 |
Why?
| | Cocaine-Related Disorders | 1 | 2018 | 107 | 0.140 |
Why?
| | Population Surveillance | 1 | 2020 | 397 | 0.140 |
Why?
| | Data Collection | 1 | 2020 | 636 | 0.140 |
Why?
| | Psychological Trauma | 1 | 2017 | 55 | 0.140 |
Why?
| | Social Determinants of Health | 1 | 2018 | 138 | 0.140 |
Why?
| | Program Evaluation | 3 | 2017 | 839 | 0.140 |
Why?
| | Comorbidity | 2 | 2018 | 1476 | 0.140 |
Why?
| | Treatment Outcome | 10 | 2019 | 9164 | 0.140 |
Why?
| | Glucose | 1 | 2021 | 904 | 0.140 |
Why?
| | Career Choice | 1 | 2018 | 182 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2020 | 552 | 0.130 |
Why?
| | Algorithms | 2 | 2020 | 1492 | 0.130 |
Why?
| | Hemorrhage | 2 | 2017 | 615 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2209 | 0.130 |
Why?
| | Femoral Artery | 1 | 2017 | 168 | 0.130 |
Why?
| | Vascular Calcification | 1 | 2017 | 108 | 0.130 |
Why?
| | Medication Errors | 1 | 2016 | 89 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 905 | 0.130 |
Why?
| | Research Report | 1 | 2016 | 76 | 0.130 |
Why?
| | Prognosis | 2 | 2021 | 3341 | 0.130 |
Why?
| | Infant | 2 | 2018 | 8000 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 230 | 0.120 |
Why?
| | Myocardial Ischemia | 1 | 2016 | 238 | 0.120 |
Why?
| | Saphenous Vein | 1 | 2014 | 31 | 0.120 |
Why?
| | Child, Preschool | 2 | 2018 | 9171 | 0.120 |
Why?
| | Drug-Eluting Stents | 1 | 2014 | 62 | 0.120 |
Why?
| | Antimicrobial Stewardship | 1 | 2016 | 93 | 0.120 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 72 | 0.120 |
Why?
| | Premature Birth | 1 | 2017 | 278 | 0.120 |
Why?
| | Stents | 2 | 2014 | 477 | 0.120 |
Why?
| | Retrospective Studies | 10 | 2020 | 12609 | 0.110 |
Why?
| | Patient Selection | 2 | 2016 | 656 | 0.110 |
Why?
| | Overweight | 1 | 2017 | 468 | 0.110 |
Why?
| | Renal Dialysis | 1 | 2017 | 371 | 0.110 |
Why?
| | Databases, Factual | 4 | 2019 | 1148 | 0.110 |
Why?
| | Anti-Bacterial Agents | 2 | 2020 | 1486 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2016 | 400 | 0.100 |
Why?
| | Blood Glucose | 1 | 2021 | 1823 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2017 | 486 | 0.100 |
Why?
| | Chi-Square Distribution | 3 | 2018 | 502 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1742 | 0.100 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 491 | 0.100 |
Why?
| | Insulin | 1 | 2021 | 2081 | 0.100 |
Why?
| | Military Personnel | 1 | 2018 | 526 | 0.100 |
Why?
| | Coronary Disease | 1 | 2013 | 349 | 0.100 |
Why?
| | Hospitals, Veterans | 3 | 2018 | 245 | 0.090 |
Why?
| | Biomarkers | 1 | 2021 | 3473 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4445 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3086 | 0.090 |
Why?
| | Prevalence | 4 | 2018 | 2269 | 0.090 |
Why?
| | Pediatrics | 1 | 2018 | 986 | 0.090 |
Why?
| | Aged, 80 and over | 5 | 2020 | 6434 | 0.090 |
Why?
| | Hospitalization | 2 | 2016 | 1758 | 0.090 |
Why?
| | Stroke | 1 | 2018 | 1014 | 0.090 |
Why?
| | Colorado | 1 | 2018 | 4120 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2014 | 771 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4668 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 819 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1751 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2021 | 2435 | 0.060 |
Why?
| | Immunoglobulins | 2 | 1974 | 148 | 0.060 |
Why?
| | Logistic Models | 2 | 2017 | 1865 | 0.050 |
Why?
| | Diet Surveys | 1 | 2021 | 78 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 533 | 0.050 |
Why?
| | Lipase | 1 | 2021 | 65 | 0.050 |
Why?
| | Patient Readmission | 2 | 2017 | 607 | 0.050 |
Why?
| | Forehead | 1 | 2020 | 5 | 0.050 |
Why?
| | Genetic Markers | 1 | 2021 | 337 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 68 | 0.040 |
Why?
| | Sodium Bicarbonate | 1 | 2020 | 40 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 2020 | 83 | 0.040 |
Why?
| | Quality Improvement | 2 | 2018 | 956 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 100 | 0.040 |
Why?
| | Gene-Environment Interaction | 1 | 2021 | 194 | 0.040 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 86 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 684 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 75 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2020 | 144 | 0.040 |
Why?
| | Child Behavior | 1 | 2021 | 218 | 0.040 |
Why?
| | Oceania | 1 | 2018 | 2 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 50 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 778 | 0.040 |
Why?
| | Skin | 1 | 2023 | 668 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2020 | 278 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2020 | 241 | 0.040 |
Why?
| | North America | 1 | 2018 | 262 | 0.040 |
Why?
| | Europe | 1 | 2018 | 352 | 0.040 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 19 | 0.040 |
Why?
| | Self Report | 1 | 2021 | 701 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2020 | 748 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2020 | 251 | 0.040 |
Why?
| | Punctures | 1 | 2017 | 37 | 0.040 |
Why?
| | Myeloma Proteins | 2 | 1974 | 7 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2020 | 605 | 0.040 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 193 | 0.040 |
Why?
| | Transfusion Reaction | 1 | 2017 | 66 | 0.030 |
Why?
| | Adsorption | 2 | 1974 | 127 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 174 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2018 | 336 | 0.030 |
Why?
| | Contraindications | 1 | 2016 | 85 | 0.030 |
Why?
| | Adolescent Behavior | 1 | 2021 | 483 | 0.030 |
Why?
| | Drug Labeling | 1 | 2016 | 42 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2016 | 56 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2016 | 69 | 0.030 |
Why?
| | Health Behavior | 1 | 2021 | 707 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2017 | 308 | 0.030 |
Why?
| | Risk-Taking | 1 | 2018 | 333 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2021 | 1033 | 0.030 |
Why?
| | Device Removal | 1 | 2016 | 128 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1652 | 0.030 |
Why?
| | Bioprosthesis | 1 | 2014 | 35 | 0.030 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 1974 | 54 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 970 | 0.030 |
Why?
| | Angina, Unstable | 1 | 2014 | 72 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2018 | 431 | 0.030 |
Why?
| | Health Promotion | 1 | 2020 | 690 | 0.030 |
Why?
| | Mortality | 1 | 2016 | 293 | 0.030 |
Why?
| | Metals | 1 | 2014 | 110 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1444 | 0.030 |
Why?
| | Mental Health | 1 | 2018 | 573 | 0.030 |
Why?
| | Patient Safety | 1 | 2016 | 275 | 0.030 |
Why?
| | Pilot Projects | 1 | 2017 | 1374 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2017 | 644 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1817 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1403 | 0.030 |
Why?
| | Antibodies | 1 | 1973 | 374 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1602 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 862 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2424 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2016 | 1262 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2020 | 2165 | 0.020 |
Why?
| | Medicare | 1 | 2013 | 665 | 0.020 |
Why?
| | Heart Failure | 1 | 2020 | 1958 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2013 | 4445 | 0.020 |
Why?
| | Immune Sera | 2 | 1974 | 80 | 0.010 |
Why?
| | Antibody Specificity | 2 | 1974 | 180 | 0.010 |
Why?
| | Rabbits | 2 | 1974 | 753 | 0.010 |
Why?
| | Immunoglobulin M | 2 | 1974 | 251 | 0.010 |
Why?
| | Immunoglobulin G | 2 | 1974 | 782 | 0.010 |
Why?
| | Immunodiffusion | 1 | 1974 | 9 | 0.010 |
Why?
| | Antibody-Producing Cells | 1 | 1974 | 29 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1974 | 128 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 1974 | 72 | 0.010 |
Why?
| | Globulins | 1 | 1973 | 1 | 0.010 |
Why?
| | Immunoelectrophoresis | 1 | 1973 | 6 | 0.010 |
Why?
| | Chloroform | 1 | 1973 | 4 | 0.010 |
Why?
| | Microsomes | 1 | 1973 | 24 | 0.010 |
Why?
| | Species Specificity | 1 | 1974 | 555 | 0.010 |
Why?
| | Antibody Formation | 1 | 1974 | 273 | 0.010 |
Why?
| | Solubility | 1 | 1973 | 227 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1974 | 779 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1974 | 1165 | 0.010 |
Why?
| | Ethanol | 1 | 1973 | 549 | 0.010 |
Why?
| | Cell Differentiation | 1 | 1974 | 1706 | 0.000 |
Why?
| | Animals | 2 | 1974 | 32113 | 0.000 |
Why?
| | Mice | 1 | 1974 | 15067 | 0.000 |
Why?
|
|
Stanislawski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|